Studies and adverse event reports have associated GLP-1 medications with an increased risk of non-arteritic anterior ischemic optic neuropathy (NAION), which can lead to vision loss
Existing relevant studies have confirmed that GLP-1RAs can inhibit the activation of the NF-B signaling pathway through a variety of mechanisms, thereby exerting their anti-inflammatory effects
Low dose opioids may be recommended for short-term use
Pentapeptide A peptide made from five amino acids
317 Neurodegenerative disorders and protein homeostasis Neurodegenerative disorders (NDDs) are characterized by a progressive loss of neuronal structure and function, leading to cognitive, motor, and behavioral impairments
While adjusting for adherence variables handles the front-end projection, the hidden structural hurdle commercial analytics teams face when trying to scale robust market access models is what we track as the "Logic Burden" on the backend